Virtual Reality-Assisted Exercise in Pediatric Hematopoietic Stem Cell Transplantation
VR-HSCT
Effects of Virtual Reality-Assisted Video Game-Based Exercise Training on Functional Level, Respiratory Parameters, and Physical Fitness in Pediatric Patients After Hematopoietic Stem Cell Transplantation
1 other identifier
interventional
38
1 country
1
Brief Summary
This randomized controlled, single-blind clinical trial investigates whether virtual reality (VR)-assisted, video game-based exercise training, added to a conventional pulmonary physiotherapy and rehabilitation program, improves functional level, respiratory parameters, and physical fitness in pediatric patients (5-18 years) following hematopoietic stem cell transplantation (HSCT). Participants attended 24 supervised, face-to-face exercise sessions over 8 weeks (3×/week) under physiotherapist supervision. The Experimental Group received game-based exercise using the Nintendo Wii Fit U platform with the Wii Balance Board and the Breathing Labs Breathing Games software (Slovenia) in addition to the conventional program. Outcomes included the Modified Alpha-Fit Pediatric Test Battery (vertical jump, 6-minute walk test, sit-and-reach, flamingo balance), upper-extremity isometric muscle strength (handheld dynamometry) and handgrip strength (Jamar), pulmonary function tests, maximal inspiratory and expiratory mouth pressures, accessory respiratory muscle architecture by myotonometry (MyotonPro: sternocleidomastoid, upper trapezius, pectoralis major), and ultrasound assessment of pleural thickness, diaphragm thickness, and diaphragm excursion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
June 17, 2026
CompletedJune 17, 2026
June 1, 2026
8 months
April 29, 2026
June 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Vertical Jump Test
Component of the Modified Alpha-Fit Pediatric Test Battery. Participant first reaches the maximum standing-reach height with one arm, then jumps vertically to the maximum reachable height; the difference between the two marks is recorded in centimeters. The best of two trials is retained. Higher values indicate greater lower-extremity power. Safety Issue: No.
Baseline to Week 8
Diaphragm Ultrasound
Right-hemidiaphragm thickness measured at end-expiration in the 9th intercostal space (anterior axillary line) using B-mode ultrasonography with a 7 MHz transducer (Toshiba Aplio XG, Tokyo, Japan). Right-hemidiaphragm excursion measured by M-mode with a 3.5 MHz curved-array transducer during quiet breathing, deep breathing, and sniff testing. Mean of three respiratory cycles reported in millimeters. Left hemidiaphragm not assessed due to image-quality limitations.
Baseline to Week 8
Secondary Outcomes (9)
Six-Minute Walk Test
Baseline to Week 8
Sit-and-Reach Test
Baseline to Week 8
Flamingo Balance Test
Baseline to Week 8
Upper-Extremity Isometric Muscle Strength
Baseline to Week 8
Handgrip Strength
Baseline to Week 8
- +4 more secondary outcomes
Study Arms (2)
Arm 1 - Active Comparator: Control Group (CG)
ACTIVE COMPARATORConventional pulmonary physiotherapy and rehabilitation program delivered as 24 supervised face-to-face sessions across 8 weeks (3×/week) under physiotherapist supervision. Each session lasted 25 minutes and included diaphragmatic breathing, thoracic expansion exercises (chest and bilateral segmental), incentive spirometry (Triflo® or Voldyne®), postural drainage and percussion, cough technique training, breathing control, and range-of-motion exercises (2 sets × 5 repetitions with 5-6 tidal-breath rest). Intensity targeted Modified Borg Scale 4-6.
Arm 2 - Experimental: VR-Assisted Game-Based Exercise + Conventional Physiotherapy (EG)
EXPERIMENTALIdentical conventional pulmonary physiotherapy program PLUS virtual reality-assisted, video game-based exercise delivered concurrently in 24 supervised face-to-face sessions across 8 weeks (3×/week). Game-based component combined the Breathing Labs Breathing Games (5 games with progressive difficulty) and Nintendo Wii Fit U with the Wii Balance Board (8 balance/mobility games; 4 played per session at 5 minutes each). Intensity titrated by Modified Borg Scale (target 4-6).
Interventions
Physiotherapist-led pulmonary rehabilitation program (24 sessions; 3×/week × 8 weeks). Components: diaphragmatic breathing, thoracic expansion exercises, incentive spirometry, postural drainage with percussion, cough techniques, breathing control, and range-of-motion exercises. Intensity titrated by Modified Borg Scale (target 4-6).
Eligibility Criteria
You may qualify if:
- Currently receiving care in a pediatric bone marrow transplantation unit (post-HSCT).
- Age between 5 and 18 years (inclusive).
- Able to perform pursed-lip breathing with expiration ≥ 3 seconds.
- Ambulatory and able to cooperate with verbal instructions.
- Clinically stable as confirmed by the treating physician at the time of enrollment.
- No history of orthopedic, neurological, or cardiac disease.
You may not qualify if:
- Facial palsy.
- Severe visual impairment or visual field defects.
- Aphasia.
- History of abdominal or thoracic surgery.
- During study: medically unstable status; new diagnosis of cutaneous graft-versus-host disease (GvHD) requiring high-dose steroid therapy; respiratory-tract or systemic infection requiring isolation; new psychiatric illness with poor prognosis; relocation precluding follow-up; withdrawal of consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istinye Universitylead
- Health Institutes of Turkeycollaborator
Study Sites (1)
Istinye University
Istanbul, 34010, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor was blinded to group allocation. Participants and treating physiotherapists were not blinded due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor; PhD
Study Record Dates
First Submitted
April 29, 2026
First Posted
June 17, 2026
Study Start
January 16, 2025
Primary Completion
August 30, 2025
Study Completion
September 15, 2025
Last Updated
June 17, 2026
Record last verified: 2026-06